Written by Holly Alyssa MacCormick Cory R. Nicholas presenting at the January 29 ICOC board meeting Roughly 3 million adults living in the United States have epilepsy, and about 400,000 of these people live in California, according to the CDC. Of these people, about one-third to half continue to have seizures that do not respond to medications on the market. It’s those patients who don’t respond to medications that Neurona Therapeutics is hoping … Continue reading Closer to Cures: Cory R. Nicholas, CEO and co-founder of Neurona Therapeutics, discusses progress in clinical trials for patients with epilepsy that does not respond to drugs.